Zobrazeno 1 - 10
of 180
pro vyhledávání: '"M D, Pescovitz"'
Autor:
A, Humar, A, Asberg, D, Kumar, A, Hartmann, G, Moussa, A, Jardine, H, Rollag, H, Mouas, C G, Gahlemann, M D, Pescovitz, Michael, Zakliczynsk
Publikováno v:
American Journal of Transplantation. 9:374-381
The effect of herpesvirus co-infections (HHV-6, HHV-7) on cytomegalovirus (CMV) disease and its response to therapy is unknown. We prospectively analyzed herpesvirus co-infections in transplant recipients with CMV disease. All patients received 3 wee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba9fd25a0a732d18a40116764f59be07
https://doi.org/10.1111/j.1600-6143.2008.02501.x
https://doi.org/10.1111/j.1600-6143.2008.02501.x
Autor:
R. Ferguson, Mark H. Deierhoi, Thomas A. Gonwa, E. Hodge, S. Cho, S. Weinstein, C. Johnson, Donald A. Norman, S. Tomlanovich, J. L. Neylan, H. W. Sollinger, M. M. Rees, E. Ramos, G. Danovitch, M. D. Pescovitz, W. Wang, Joshua Miller
Publikováno v:
American Journal of Kidney Diseases. 34:296-303
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d1a2b099fa6a4dffbc88729b2807867
https://doi.org/10.1016/s0272-6386(99)70358-6
https://doi.org/10.1016/s0272-6386(99)70358-6
Autor:
M D, Pescovitz, R B, Ettenger, C F, Strife, J R, Sherbotie, S E, Thomas, S, McDiarmid, S, Bartosh, J, Ives, M R, Bouw, J, Bucuvalas
Publikováno v:
Transplant infectious disease : an official journal of the Transplantation Society. 12(3)
In an open-label, prospective, pharmacokinetic assessment, we evaluated total drug exposure (area under the curve [AUC]) of intravenous (IV) ganciclovir (GCV) and oral (p.o.) valganciclovir when normalized for body surface area (BSA) in pediatric liv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::afa6149c0add58f9fd5ece20258ad478
https://pubmed.ncbi.nlm.nih.gov/20002356
https://pubmed.ncbi.nlm.nih.gov/20002356
Autor:
R. S. Filo, S. B. Leapman, L. Lumeng, M. D. Pescovitz, M. H. Kabeer, Rahul M. Jindal, M. L. Milgrom
Publikováno v:
Postgraduate Medical Journal. 71:239-241
Central pontine myelinolysis can occur after orthotopic liver transplantation leading to high mortality and serious morbidity. In our case, central pontine myelinolysis was associated with wide fluctuations in cyclosporine levels during an episode of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::414d30e82d3bb1ae084a271fb9e476e1
https://doi.org/10.1136/pgmj.71.834.239
https://doi.org/10.1136/pgmj.71.834.239
Autor:
G L, Bumgardner, I, Hardie, R W, Johnson, A, Lin, B, Nashan, M D, Pescovitz, E, Ramos, F, Vincenti
Publikováno v:
Transplantation. 72(5)
Daclizumab (Zenapax, Roche Pharmaceuticals), a humanized monoclonal antibody directed against the alpha chain of the interleukin 2 receptor, has been shown to reduce the incidence of acute rejection at 6 months after renal transplantation in two phas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::aa4d33cde1eccafe72d918fe55c4d288
https://pubmed.ncbi.nlm.nih.gov/11571447
https://pubmed.ncbi.nlm.nih.gov/11571447
Autor:
J M, Kovarik, M D, Pescovitz, H W, Sollinger, B, Kaplan, C, Legendre, K, Salmela, B K, Book, C, Gerbeau, D, Girault, K, Somberg
Publikováno v:
Clinical transplantation. 15(2)
Pharmacokinetic sampling was performed in two multicenter trials in which basiliximab (anti-CD25 monoclonal antibody) was administered with triple immunosuppression consisting of cyclosporine microemulsion, corticosteroids, and either azathioprine or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a1b8fcca6157e4a9d8cb0ab09ab192f4
https://pubmed.ncbi.nlm.nih.gov/11264639
https://pubmed.ncbi.nlm.nih.gov/11264639
Publikováno v:
Transplantation. 68(10)
The novel agent sirolimus (SRL; Rapamune; rapamycin) inhibits the immune response by a mechanism distinct from those of calcineurin antagonists or antimetabolites. This randomized, controlled, multicenter, single blind, phase II trial examined the co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2cb302a1814cd6482d59f36296c61936
https://pubmed.ncbi.nlm.nih.gov/10589950
https://pubmed.ncbi.nlm.nih.gov/10589950
Publikováno v:
Transplantation. 68(2)
Daclizumab is a newly developed humanized anti-IL-2 receptor monoclonal antibody. We describe the effect of adding daclizumab to conventional dual or triple cyclosporine A immunosuppressive therapy on the incidence and nature of cytomegalovirus (CMV)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::911b58a79cfd9d39dd55729fb9b2260a
https://pubmed.ncbi.nlm.nih.gov/10755575
https://pubmed.ncbi.nlm.nih.gov/10755575
Autor:
L K, Dalla Vecchia, B K, Book, M L, Milgrom, R M, Jindal, S B, Leapman, R S, Filo, M D, Pescovitz
Publikováno v:
Transplantation. 64(12)
Measurement of panel-reactive antibody (PRA) with an enzyme-linked immunosorbent assay using soluble HLA class I molecules (PRA-STAT) in adult renal transplant recipients predicted graft loss and rejection. We sought to confirm this finding in pediat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8e71806c75ae68bf1831acd1a9d0d389
https://pubmed.ncbi.nlm.nih.gov/9422414
https://pubmed.ncbi.nlm.nih.gov/9422414
Publikováno v:
Clinical transplantation. 11(6)
An oral formulation of ganciclovir (GAN) has been shown to be effective as prophylaxis of cytomegalovirus (CMV) after liver transplantation in an adult population. There are no data on the use or dose of oral GAN in pediatric transplant recipients. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ea59f2bb52e3604e9c975f5de3d32e61
https://pubmed.ncbi.nlm.nih.gov/9408695
https://pubmed.ncbi.nlm.nih.gov/9408695